"Through FY 2021-22, RIL put social responsibility initiatives, health and well-being of communities at the top of its agenda," CSR report ...

Hester said its Board has approved the execution of Grantin-Aid Letter Agreement for grant of Rs 60 crore in a phased manner to the company...

As variants of concern of COVID-19 emerged in the country, the Indian SARS-CoV-2 Genomics Consortium (INSACOG), studied over 80,000 genome ...

BBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...

Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be wel...

From January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...

Union Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...

Soon after the government opened up vaccination for private companies, Reliance Foundation launched the vaccination drive in April, sources...

In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's D...

Speaking at the 44th Annual General Meeting (AGM) of RIL, Nita Ambani said, "The Covid-19 pandemic is a humanitarian crisis. It has tested ...

He also assured all possible support and smooth approval process for the vaccine candidates which are currently under trial phase. The heal...

The DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...

Indian vaccine makers such as Serum Institute and Bharat Biotech have appealed to the government to fund the expansion of their vaccine man...

The company has written to the Department of Biotechnology seeking Rs 100 crore to ramp up its manufacturing capacity.

"The public spend in healthcare needs to increase from the current 1.2 per cent to at least 2.5 per cent of GDP in the next 3 years, much o...

While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...

The proposed mission will also look to ensure that sufficient volumes are manufactured to meet India's COVID-19 vaccine requirement and to ...